Israeli Agricultural Technology Firm Kaiima Raises $65M | GenomeWeb

NEW YORK (GenomeWeb News) – Israeli seed and breeding technology firm Kaiima Bio Agri-Tech today announced it closed on a financing round that raised US$65 million.

Three new investors participated in the round — Horizons Ventures; the International Financial Corporation, a member of the World Bank Group; and the Infinity Group. Participating existing investors included Draper Fisher Jurvetson; DFJ-Tamir Fishman Ventures; Mitsui Global Investment; Kleiner Perkins Caufield & Byers; Oberlee; and Musea Ventures.

Kaiima did not specify how the financing will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.